Study of pancreas cancer risk in families and environment
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have a confirmed diagnosis or meeting a study group type (cancer, specific pancreas/liver/intestinal condition, or healthy control)
- If in the cancer group, your diagnosis must be confirmed by pathology or scans
- If you are in a control group, you must have one of the listed conditions (like acute/chronic pancreatitis, biliary blockage, or a pancreatic cyst)
- If you’re a healthy control, you should not have any of the listed conditions
- If you join the family high-risk group, you must have at least one close relative with pancreatic cancer and be able to travel to Pittsburgh for in-person enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study is building a registry of people with a strong family history of pancreatic cancer. By joining, you help researchers learn more about who is at risk and how to detect it early.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.